Eukaryotic translation initiation factor 3, subunit a, regulates the extracellular signal-regulated kinase pathway

Molecular and Cellular Biology

Volumn 32, Issue 1, 2012, Pages 88-95

  Xu, Tian Rui ^a   Lu, Rui Fang ^a   Romano, David ^b   Pitt, Andrew ^a,c   Houslay, Miles D ^a   Milligan, Graeme ^a   Kolch, Walter ^a,b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

^c ASTON UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ARRESTIN 2; EPIDERMAL GROWTH FACTOR; EUKARYOTIC TRANSLATION INITIATION FACTOR 3A; INITIATION FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; RAF PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CELL STRAIN 3T3; CELL STRAIN HEK293; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; GENE EXPRESSION; GENE SILENCING; IN VITRO STUDY; NERVE CELL DIFFERENTIATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ANIMALS; ARRESTINS; CELL DIFFERENTIATION; EPIDERMAL GROWTH FACTOR; EUKARYOTIC INITIATION FACTOR-3; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE KNOCKDOWN TECHNIQUES; HEK293 CELLS; HUMANS; MAP KINASE SIGNALING SYSTEM; MICE; NIH 3T3 CELLS; PC12 CELLS; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-RAF; RATS;

EID: 84856771997     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.05770-11     Document Type: Article

References (46)

1. Abraham D, et al. 2000. Raf-1-associated protein phosphatase 2A as a positive regulator of kinase activation. J. Biol. Chem. 275:22300-22304.
2. Adams DG, et al. 2005. Positive regulation of Raf1-MEK1/2-ERK1/2 signaling by protein serine/threonine phosphatase 2A holoenzymes. J. Biol. Chem. 280:42644-42654.
3. Ahn S, Wei H, Garrison TR, Lefkowitz RJ. 2004. Reciprocal regulation of angiotensin receptor-activated extracellular signal-regulated kinases by beta-arrestins 1 and 2. J. Biol. Chem. 279:7807-7811.
4. Baillie GS, Houslay MD. 2005. Arrestin times for compartmentalized cAMP signaling and phosphodiesterase-4 enzymes. Curr. Opin. Cell Biol. 17:129-134.
5. Calvo F, Agudo-Ibanez L, Crespo P. 2010. The Ras-ERK pathway: understanding site-specific signaling provides hope of new anti-tumor therapies. Bioessays 32:412-421.
6. D'Arcangelo G, Halegoua S. 1993. A branched signaling pathway for nerve growth factor is revealed by Src-, Ras-, and Raf-mediated gene inductions. Mol. Cell. Biol. 13:3146-3155.
7. Damoc E, et al. 2007. Structural characterization of the human eukaryotic initiation factor 3 protein complex by mass spectrometry. Mol. Cell Proteomics 6:1135-1146.
8. Defea K. 2008. Beta-arrestins and heterotrimeric G-proteins: collaborators and competitors in signal transduction. Br. J. Pharmacol. 153(Suppl. 1):S298-S309.
9. DeFea KA. 2011. Beta-arrestins as regulators of signal termination and transduction: how do they determine what to scaffold? Cell Signal. 23: 621-629.
10. DeWire SM, Ahn S, Lefkowitz RJ, Shenoy SK. 2007. Beta-arrestins and cell signaling. Annu. Rev. Physiol. 69:483-510.
11. Dhillon AS, Hagan S, Rath O, Kolch W. 2007. MAP kinase signalling pathways in cancer. Oncogene 26:3279-3290.
12. Dhillon AS, Meikle S, Yazici Z, Eulitz M, Kolch W. 2002. Regulation of Raf-1 activation and signalling by dephosphorylation. EMBO J. 21:64-71.
13. Dhillon AS, von Kriegsheim A, Grindlay J, Kolch W. 2007. Phosphatase and feedback regulation of Raf-1 signaling. Cell Cycle 6:3-7.
14. Diaz B, et al. 1997. Phosphorylation of Raf-1 serine 338-serine 339 is an essential regulatory event for Ras-dependent activation and biological signaling. Mol. Cell. Biol. 17:4509-4516.
15. Dong Z, Liu LH, Han B, Pincheira R, Zhang JT. 2004. Role of eIF3 p170 in controlling synthesis of ribonucleotide reductase M2 and cell growth. Oncogene 23:3790-3801.
16. Dong Z, Zhang JT. 2003. EIF3 p170, a mediator of mimosine effect on protein synthesis and cell cycle progression. Mol. Biol. Cell 14:3942-3951.
17. Dong Z, Zhang JT. 2006. Initiation factor eIF3 and regulation of mRNA translation, cell growth, and cancer. Crit. Rev. Oncol. Hematol. 59: 169-180.
18. Gesty-Palmer D, et al. 2006. Distinct beta-arrestin- and G proteindependent pathways for parathyroid hormone receptor-stimulated ERK1/2 activation. J. Biol. Chem. 281:10856-10864.
19. Gesty-Palmer D, El Shewy H, Kohout TA, Luttrell LM. 2005. β-Arrestin 2 expression determines the transcriptional response to lysophosphatidic acid stimulation in murine embryo fibroblasts. J. Biol. Chem. 280: 32157-32167.
20. Hasek J, et al. 2000. Rpg1p, the subunit of the Saccharomyces cerevisiae eIF3 core complex, is a microtubule-interacting protein. Cell Motil. Cytoskeleton 45:235-246.
21. Haybaeck J, et al. 2010. Overexpression of p150, a part of the large subunit of the eukaryotic translation initiation factor 3, in colon cancer. Anticancer Res. 30:1047-1055.
22. Hinnebusch AG. 2006. eIF3: a versatile scaffold for translation initiation complexes. Trends Biochem. Sci. 31:553-562.
23. Jainchill JL, Aaronson SA, Todaro GJ. 1969. Murine sarcoma and leukemia viruses: assay using clonal lines of contact-inhibited mouse cells. J. Virol. 4:549-553.
24. Jaumot M, Hancock JF. 2001. Protein phosphatases 1 and 2A promote Raf-1 activation by regulating 14-3-3 interactions. Oncogene 20: 3949-3958.
25. Karin M. 1996. The regulation of AP-1 activity by mitogen-activated protein kinases. Philos Trans. R. Soc. Lond. B Biol. Sci. 351:127-134.
26. Kholodenko BN, Hancock JF, Kolch W. 2010. Signalling ballet in space and time. Nat. Rev. Mol. Cell. Biol. 11:414-426.
27. Lin L, Holbro T, Alonso G, Gerosa D, Burger MM. 2001. Molecular interaction between human tumor marker protein p150, the largest subunit of eIF3, and intermediate filament protein K7. J. Cell Biochem. 80: 483-490.
28. Luc PV, Wagner JA. 1997. Regulation of the neural-specific gene VGF in PC12 cells: identification of transcription factors interacting with NGFresponsive elements. J. Mol. Neurosci. 8:223-241.
29. Luttrell LM, et al. 2001. Activation and targeting of extracellular signalregulated kinases by beta-arrestin scaffolds. Proc. Natl. Acad. Sci. U. S. A. 98:2449-2454.
30. MacDonald JI, Verdi JM, Meakin SO. 1999. Activity-dependent interaction of the intracellular domain of rat trkA with intermediate filament proteins, the beta-6 proteasomal subunit, Ras-GRF1, and the p162 subunit of eIF3. J. Mol. Neurosci. 13:141-158.
31. Marshall CJ. 1995. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80:179-185.
32. McKay MM, Morrison DK. 2007. Integrating signals from RTKs to ERK/MAPK. Oncogene 26:3113-3121.
33. Murphy LO, Blenis J. 2006. MAPK signal specificity: the right place at the right time. Trends Biochem. Sci. 31:268-275.
34. Pincheira R, Chen Q, Huang Z, Zhang JT. 2001. Two subcellular localizations of eIF3 p170 and its interaction with membrane-bound microfilaments: implications for alternative functions of p170. Eur. J. Cell Biol. 80:410-418.
35. Rajagopal S, Rajagopal K, Lefkowitz RJ. 2010. Teaching old receptors new tricks: biasing seven-transmembrane receptors. Nat. Rev. Drug Discov. 9:373-386.
36. Saletta F, Rahmanto YS, Richardson DR. 2010. The translational regulator eIF3a: the tricky eIF3 subunit! Biochim. Biophys. Acta 1806:275-286.
37. Severin FF, et al. 1997. A major 170-kDa protein associated with bovine adrenal medulla microtubules: a member of the centrosomin family? FEBS Lett. 420:125-128.
38. Shankaran H, Wiley HS. 2010. Oscillatory dynamics of the extracellular signal-regulated kinase pathway. Curr. Opin. Genet. Dev. 20:650-655.
39. Shaul YD, Seger R. 2007. The MEK/ERK cascade: from signaling specificity to diverse functions. Biochim. Biophys. Acta 1773:1213-1226.
40. Silvera D, Formenti SC, Schneider RJ. 2010. Translational control in cancer. Nat. Rev. Cancer 10:254-266.
41. Tohgo A, Pierce KL, Choy EW, Lefkowitz RJ, Luttrell LM. 2002. β-Arrestin scaffolding of the ERK cascade enhances cytosolic ERK activity but inhibits ERK-mediated transcription following angiotensin AT1a receptor stimulation. J. Biol. Chem. 277:9429-9436.
42. von Kriegsheim A, et al. 2009. Cell fate decisions are specified by the dynamic ERK interactome. Nat. Cell Biol. 11:1458-1464.
43. Wu YY, Bradshaw RA. 1996. Synergistic induction of neurite outgrowth by nerve growth factor or epidermal growth factor and interleukin-6 in PC12 cells. J. Biol. Chem. 271:13033-13039.
44. Xu TR, et al. 2008. Mutations of beta-arrestin 2 that limit self-association also interfere with interactions with the beta2-adrenoceptor and the ERK1/2 MAPKs: implications for β2-adrenoceptor signaling via the ERK1/2 MAPKs. Biochem. J. 413:51-60.
45. Yoon S, Seger R. 2006. The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions. Growth Factors 24:21-44.
46. Zhang L, Pan X, Hershey JW. 2007. Individual overexpression of five subunits of human translation initiation factor eIF3 promotes malignant transformation of immortal fibroblast cells. J. Biol. Chem. 282: 5790-5800.